New study offers first glimpse into how widespread COVID-19 antibodies are in Canada’s adult population – McGill Newsroom

Today, Canadian Blood Servicesand Canadas COVID-19 Immunity Task Force (CITF)are releasing initial results of the first 10,000 blood donor samples assessed for SARS-CoV-2 antibodies. This analysis reveals that over the period May 9 through June 8, 2020, fewer than 1 per cent of the 10,000 samples from blood donors tested positive for antibodies to the novel coronavirus

Read more
FDA Approves New CAR-T Therapy for Mantle Cell Lymphoma – Cancer Health Treatment News

On July 24, the Food and Drug Administration (FDA) granted accelerated approval of a new CAR-T therapy, Tecartus (brexucabtagene autoleucel), for adults with mantle cell lymphoma who have not responded to or who have relapsed after other kinds of treatment. Tecartus (formerly known as KTE-X19), manufactured by Kite, a Gilead Company, is a living drug that reprograms a patients own T cells to fight cancer. About two thirds of participants treated in the ZUMA-2 study experienced complete remission, which in a majority of cases lasted at least a year.

Read more
Of mice and SARS-CoV-2 – The Hindu

Science and research have always relied on using animals to understand various human diseases. The primarily reasons have been the genetic similarity between animals and humans (mice share 98% of DNA with us), and that we have developed tools to edit genes in various animals.

Read more
R3 International Now Including Exosomes with Stem Cell Therapy Program for Autism in Mexico – Yahoo Finance

R3 International is now including exosomes with its stem cell therapy program in Mexico for autism. They have been shown to be an effective, safe option for autism patients. SCOTTSDALE, Ariz., July 23, 2020 /PRNewswire-PRWeb/ --R3 International is now including exosomes with its stem cell therapy program in Mexico for autism

Read more
Stem Cell Therapy Market to Surpass US$ 40.3 Billion by 2027, Owing to Increasing Incidence of Spina – PharmiWeb.com

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters. According to Global Stem Cell Therapy Market Report, by Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Others), by Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), published by Coherent Market Insights, the global stem cell therapy market was valued at US$ 7,313.6 million in 2018, and is expected to exhibit a CAGR of 21.1% over the forecast period (2019-2027). Increasing incidence of spinal cord injuries is expected to boost growth of the global stem cell therapy market over the forecast period

Read more
Celltex Therapeutics Webinar | Houston, TX Patch – Patch.com

This post was contributed by a community member. Celltex Therapeutics hosts webinar on life-changing mesenchymal stem cell banking and therapy Webinar to be hosted Wednesday, July 29 WHAT: Celltex Therapeutics, a Houston-based biotechnology company, will host a free virtual webinar Wednesday, July 29, 2020 about the benefits of utilizing your own mesenchymal stem cells (MSCs) and how they can lead to proven results and an improved quality of life.

Read more